Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

2015 ◽  
Vol 39 (9) ◽  
pp. 933-937 ◽  
Author(s):  
Mohamed A. Kharfan-Dabaja ◽  
Myriam Labopin ◽  
Ali Bazarbachi ◽  
Gerard Socie ◽  
Nicolaus Kroeger ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document